Why is SPARC falling/rising?

As of 12-Aug, Sun Pharma Advanced Research Company Ltd is currently priced at 142.10, reflecting a slight increase of 0.35 or 0.25%. The stock has shown a trend reversal by gaining after two consecutive days of decline. However, it remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock's performance over the past week has been poor, with a decline of 2.57%, and it has underperformed significantly over the past month and year, with returns of -10.88% and -33.75%, respectively. The company is facing challenges, including a negative book value and weak long-term fundamentals, as evidenced by a significant drop in net sales and a poor EBIT to interest ratio.
In the broader market context, the stock's recent performance has been inline with the sector, but it has consistently underperformed against the benchmark, the Sensex, which has shown a modest gain of 2.68% year-to-date. The delivery volume has also decreased by 29.15% compared to the 5-day average, indicating falling investor participation. This lack of interest, combined with the company's negative financial indicators and consistent underperformance over the last three years, suggests that the stock is facing significant headwinds, contributing to its overall decline in value.